FGF21 and metabolic dysfunction-associated steatotic liver disease: FGF21 is implicated in NAFLD development and disease progression to NASH; in fact, NAFLD and NASH are felt to be FGF21-resistant states, where an elevated serum FGF21 is observed as a compensatory response [14,15].